Researchers from The Wistar Institute identified proteins in Epstein-Barr virus-infected cells that decreased expression of genes linked to the spread of the virus, with implications for cancer research.
The Wistar Institute is collaborating with Accelerated Biosciences Corp. to create a platform based on human trophoblast stem cells to explore new immunotherapies that use Accelerated Bio’s proprietary technology. This collaboration could generate various types of immune cells from hTSCs, changing the field of allogeneic immunotherapies.
